ArticleOncotarget2017

In-vivo relation between plasma concentration of sorafenib and its safety in Chinese patients with metastatic renal cell carcinoma: a single-center clinical study.

Haixing Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.